Clinical trial

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

NCT05473325

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2023-01-01

PhaseN/A

Study timeline

Study start (estimated)2023-01-01Date precision: day

Registry last updated2022-08-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Chronic Kidney Diseasesunresolved

Cancerunresolved

Bowel Diseaseunresolved

Cardiovascular Diseasesunresolved

Mononucleosisunresolved

Fluunresolved

Heart Diseasesunresolved

HIV Infectionsunresolved

AIDS and Infectionsunresolved

Bulimiaunresolved

Chest Infectionsunresolved

Arthritisunresolved

Leukaemiaunresolved

Alcoholic Liver Diseaseunresolved

Allergiesunresolved

Alzheimer Diseaseunresolved

Appendicitisunresolved

Eczemaunresolved

Bronchitisunresolved

Cellulitisunresolved

Cirrhosisunresolved

Depressionunresolved

Goutunresolved

High Cholesterolunresolved

Indigestionunresolved

Obesityunresolved

Osteoporosisunresolved

Interventions

Sponsors & collaborators

Willows Healthlead sponsor

Nottingham Trent Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05473325 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.